Evidence map›Paper›PMID 30510044›Full record

ArticleCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2018

High-strength opioid formulations: the case for a ministerial recall.

Matthew Herder, David Juurlink

Abstract read
In one paragraph

Article in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Flawed arguments in this commentary.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  2. Consider the economic burden for patients.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  3. Opioid Wisely.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  4. A recall of high-strength opioids would be harmful.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  5. Recalling high-strength opioid formulations would cause harm.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
  6. Muddling Health Canada's powers and diluting accountability.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Matthew HerderHealth Law Institute and Department of Pharmacology, Faculty of Medicine (Herder), Dalhousie University, Halifax, NS; Division of Clinical Pharmacology and Toxicology, and Medicine, Pediatrics, and Health Policy, Management and Evaluation (Juurlink), University of Toronto; Divisions of General Internal Medicine and Clinical Pharmacology & Toxicology (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont. Matthew.Herder@Dal.ca.
David JuurlinkHealth Law Institute and Department of Pharmacology, Faculty of Medicine (Herder), Dalhousie University, Halifax, NS; Division of Clinical Pharmacology and Toxicology, and Medicine, Pediatrics, and Health Policy, Management and Evaluation (Juurlink), University of Toronto; Divisions of General Internal Medicine and Clinical Pharmacology & Toxicology (Juurlink), Sunnybrook Health Sciences Centre, Toronto, Ont.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Dosage FormsAnalgesics, OpioidCanadaDrug RecallsHumansAnalgesics, OpioidDosage Forms

Identifiers

PMID30510044
PMCPMC6258213

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.